FDA bans use of Lilly, Regeneron COVID drugs due to OmicronThe FDA has limited the use of COVID-19 antibody therapies developed by Eli Lilly and Regeneron, on the Share XFDA bans use of Lilly, Regeneron COVID drugs due to Omicronhttps://pharmaphorum.com/news/fda-bans-use-of-lilly-regeneron-covid-drugs-due-to-omicron/
Regeneron hands ex-US rights to HoFH drug Evkeeza to UltragenyxRegeneron has enlisted the aid of Ultragenyx to add momentum to the rollout of its recently-approved Evkeeza outside Share XRegeneron hands ex-US rights to HoFH drug Evkeeza to Ultragenyxhttps://pharmaphorum.com/news/regeneron-hands-ex-us-rights-to-hofh-drug-evkeeza-to-ultragenyx/
Valneva gets EU deal for COVID jab, and may sue UKShares in France’s Valneva leaped after it got an EU order to supply 60 million doses of its Share XValneva gets EU deal for COVID jab, and may sue UKhttps://pharmaphorum.com/news/valneva-gets-eu-deal-for-covid-jab-and-may-sue-uk/
US buys another $1 billion-worth of Merck’s COVID capsuleThe US federal government has ordered another 1.4 million doses of Merck & Co and Ridgeback Biotherapeutics’ oral Share XUS buys another $1 billion-worth of Merck’s COVID capsulehttps://pharmaphorum.com/news/us-buys-another-1-billion-worth-of-mercks-covid-capsule/
Biogen admits slow Aduhelm launch, as scientists question label againShares in Biogen have come under pressure after chief executive Michel Vounatsos admitted that the company is facing Share XBiogen admits slow Aduhelm launch, as scientists question label againhttps://pharmaphorum.com/news/biogen-admits-slow-aduhelm-launch-as-scientists-question-label-again/
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readoutPhase 3 results with Roche’s amyloid-targeting Alzheimer’s drug gantenerumab may not be due until the second half of Share XRoche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readouthttps://pharmaphorum.com/news/roche-talking-to-fda-as-alzheimers-drug-moves-towards-2022-readout/
Healthware appoints Paolo Guglielmoni as head of experienceDigital health consulting, marketing communications group Healthware has appointed Paolo Guglielmoni as its new head of experience. He Share XHealthware appoints Paolo Guglielmoni as head of experiencehttps://pharmaphorum.com/news/healthware-paolo-guglielmoni-head-experience/
Dentsu launches global healthcare agency dentsu healthDentsu International has announced the launch of a global healthcare agency dentsu health. The New York-based marketing firm Share XDentsu launches global healthcare agency dentsu healthhttps://pharmaphorum.com/news/dentsu-launches-global-healthcare-agency-dentsu-health/
GCI Health appoints three senior staff membersGCI Health has announced the appointment of three senior roles on its UK management team, reporting to recently Share XGCI Health appoints three senior staff membershttps://pharmaphorum.com/news/gci-health-appoints-three-senior-staff-members/
